MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mjt.0000000000002250

Медицинская библиотека · American journal of therapeutics · 2026

Meta-Analysis of Long-Term Major Adverse Cardiovascular Events of Different Biologics in Psoriatic Patients.

Liu Zhifeng, Liao Caiyu, Zhou Qinyao, Wang Yufei, Yin Zhiqiang

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Psoriasis is a chronic immune-mediated inflammatory disease associated with systemic inflammation and an increased risk of cardiovascular events.

AREAS OF UNCERTAINTY: Although biologic therapies have transformed psoriasis treatment, the long-term impact of different biologic classes on major adverse cardiovascular events (MACE) remains unclear.

DATA SOURCES: A systematic search of PubMed was performed up to May 27, 2026. We included Comparative cohort studies of biologic therapies for psoriasis with follow-up durations of at least 52 weeks, as well as long-term open-label extension phases of randomized controlled trials that reported MACE outcomes. Study quality was assessed using the Newcastle-Ottawa Scale for cohort studies. Hazard ratios (HR) with 95% confidence intervals (CI) were pooled using the generic inverse variance method.

RESULTS

Four comparative cohort studies involving 57,331 patients were included in the quantitative synthesis. No significant difference in MACE risk was observed between interleukin (IL)-12/23 inhibitors and tumor necrosis factor alpha (TNF-α) inhibitors (HR: 0.91, 95% CI: 0.68-1.23), or between IL-12/23 inhibitors and IL-17 inhibitors (HR: 1.38, 95% CI: 0.73-2.62). Long-term open-label extension studies reported low MACE event rates (0%-1.33%) across biologic therapies.

CONCLUSIONS

Among biologic therapies with available long-term comparative data, no significant differences in MACE risk were observed between IL-12/23, TNF-α, and IL-17 inhibitors in patients with psoriasis. Further long-term, large-scale studies are warranted to better define the cardiovascular safety profiles of emerging biologic therapies.

Для цитирования: Liu Zhifeng, Liao Caiyu, Zhou Qinyao, Wang Yufei, Yin Zhiqiang. Meta-Analysis of Long-Term Major Adverse Cardiovascular Events of Different Biologics in Psoriatic Patients.. American journal of therapeutics. 2026. DOI: 10.1097/mjt.0000000000002250.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.